These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38249344)

  • 21. Interventions to support return to work for people with coronary heart disease.
    Hegewald J; Wegewitz UE; Euler U; van Dijk JL; Adams J; Fishta A; Heinrich P; Seidler A
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010748. PubMed ID: 30869157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
    Burton JK; Craig LE; Yong SQ; Siddiqi N; Teale EA; Woodhouse R; Barugh AJ; Shepherd AM; Brunton A; Freeman SC; Sutton AJ; Quinn TJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013307. PubMed ID: 34280303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.
    Zhang H; Chang R
    J Sports Sci Med; 2019 Jun; 18(2):213-222. PubMed ID: 31191090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Chinese patent medicines for acute myocardial infarction after percutaneous coronary intervention: A protocol for systematic review and network meta-analysis.
    Zhao W; Xiong FJ; Feng SG; Li YM; Lei XH; Jia SJ
    Medicine (Baltimore); 2022 Dec; 101(48):e31927. PubMed ID: 36482597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
    Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials.
    Sun YX; Yang GY; Karamacoska D; Wang X; Li YX; Hou WB; Zheng YY; Liu JP; Liu ZL
    Evid Based Complement Alternat Med; 2021; 2021():1075886. PubMed ID: 34484384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Yu H; Han M; Lin W; Wang L; Liu P; Yang K; Pei M; Yang H
    Front Pharmacol; 2020; 11():579241. PubMed ID: 33178022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Chinese Herbal Medicine for Depressive Disorder in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Xue YJ; Xie Y; Zhao GL; Zhou BD; Li K; Li SY; Zhang P
    Chin J Integr Med; 2020 Aug; 26(8):617-623. PubMed ID: 31222629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of drug coated balloon versus conventional balloon in the treatment of coronary de novo bifurcation lesions: a meta-analysis].
    Xie ER; Liu C; Ni YJ; Gao DF; Deng J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Dec; 49(12):1227-1234. PubMed ID: 34905901
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis.
    Al Said S; Alabed S; Kaier K; Tan AR; Bode C; Meerpohl JJ; Duerschmied D
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013252. PubMed ID: 31858590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systematic review on efficacy and safety of Danshen Chuanxiongqin Injection in treatment of acute cerebral infarction].
    Xie BC; Chen SC; Wang QH; Zhou CH; Wu JH; Xu DH
    Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(17):3573-3581. PubMed ID: 30347928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis.
    Zhang L; Liu S; Gu Y; Li S; Liu M; Zhao W
    Front Pharmacol; 2022; 13():1077180. PubMed ID: 36686656
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.
    Guo H; Zhu M; Yu R; Li X; Zhao Q
    Front Cardiovasc Med; 2023; 10():1255940. PubMed ID: 38054101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Network Meta-analysis of Chinese patent medicine in treatment of unstable angina pectoris].
    Zhang LM; DU TH; Niu LL; Wang LY; Li JN; Ma PF; Yu R
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):703-711. PubMed ID: 33645038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis.
    Zhang D; Lyu JT; Zhang B; Zhang XM; Jiang H; Lin ZJ
    BMC Complement Med Ther; 2020 Jul; 20(1):210. PubMed ID: 32631398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis.
    Lin A; Zhang Z; Liu X; Wu J
    Heliyon; 2023 Aug; 9(8):e18711. PubMed ID: 37593598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Network Meta-Analysis of the Clinical Efficacy and Safety of Commonly Used Chinese Patent Medicines in the Auxiliary Treatment of Poststroke Depression.
    Yu Y; Zhang G; Han T; Liu H; Huang H
    Evid Based Complement Alternat Med; 2022; 2022():7265769. PubMed ID: 35035507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Network Meta-analysis of Chinese patent medicines of Ziziphi Spinosae Semen in treatment of primary insomnia].
    Yao WQ; Zhao YH; Zheng YW; Zhang Q; Han X
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4541-4554. PubMed ID: 34581060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of Chinese patent medicines for tension-type headache: Systematic review and network meta-analysis.
    Shi M; Sun T; Zhang Y; Yang F; Wang H; Pang B; Ji Z; Cao L
    Heliyon; 2024 Jul; 10(13):e32798. PubMed ID: 39027600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.